CN114451487A - Eucommia ulmoides egg and production method thereof - Google Patents
Eucommia ulmoides egg and production method thereof Download PDFInfo
- Publication number
- CN114451487A CN114451487A CN202210094685.5A CN202210094685A CN114451487A CN 114451487 A CN114451487 A CN 114451487A CN 202210094685 A CN202210094685 A CN 202210094685A CN 114451487 A CN114451487 A CN 114451487A
- Authority
- CN
- China
- Prior art keywords
- eucommia ulmoides
- leaf powder
- eucommia
- ulmoides leaf
- fermented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000208689 Eucommia ulmoides Species 0.000 title claims abstract description 113
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 9
- 235000013601 eggs Nutrition 0.000 claims abstract description 59
- 239000000843 powder Substances 0.000 claims abstract description 53
- 241000208688 Eucommia Species 0.000 claims abstract description 16
- 239000000654 additive Substances 0.000 claims abstract description 15
- 239000000463 material Substances 0.000 claims description 19
- 230000002354 daily effect Effects 0.000 claims description 17
- 238000001035 drying Methods 0.000 claims description 12
- 238000000855 fermentation Methods 0.000 claims description 12
- 230000004151 fermentation Effects 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 230000000996 additive effect Effects 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 238000011081 inoculation Methods 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 9
- 241000194032 Enterococcus faecalis Species 0.000 claims description 7
- 241000287828 Gallus gallus Species 0.000 claims description 7
- 229940032049 enterococcus faecalis Drugs 0.000 claims description 7
- 238000010025 steaming Methods 0.000 claims description 7
- 238000010564 aerobic fermentation Methods 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- 241000228245 Aspergillus niger Species 0.000 claims description 5
- 240000006439 Aspergillus oryzae Species 0.000 claims description 5
- 235000002247 Aspergillus oryzae Nutrition 0.000 claims description 5
- 244000063299 Bacillus subtilis Species 0.000 claims description 5
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 4
- 238000002791 soaking Methods 0.000 claims description 4
- 239000003674 animal food additive Substances 0.000 claims description 3
- 230000003203 everyday effect Effects 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 abstract description 6
- 235000016709 nutrition Nutrition 0.000 abstract description 5
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract description 4
- 150000002327 glycerophospholipids Chemical class 0.000 abstract description 4
- 230000035764 nutrition Effects 0.000 abstract description 4
- 235000019156 vitamin B Nutrition 0.000 abstract description 4
- 239000011720 vitamin B Substances 0.000 abstract description 4
- 102000002322 Egg Proteins Human genes 0.000 description 40
- 108010000912 Egg Proteins Proteins 0.000 description 40
- 210000002969 egg yolk Anatomy 0.000 description 29
- 235000014103 egg white Nutrition 0.000 description 24
- 210000000969 egg white Anatomy 0.000 description 24
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 23
- 235000013345 egg yolk Nutrition 0.000 description 16
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 12
- 235000001014 amino acid Nutrition 0.000 description 11
- 150000001413 amino acids Chemical class 0.000 description 11
- 239000002207 metabolite Substances 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 229940045997 vitamin a Drugs 0.000 description 8
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 7
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 7
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 7
- 150000003904 phospholipids Chemical class 0.000 description 7
- 235000019155 vitamin A Nutrition 0.000 description 7
- 239000011719 vitamin A Substances 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 235000013330 chicken meat Nutrition 0.000 description 6
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 6
- 229940090949 docosahexaenoic acid Drugs 0.000 description 6
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 6
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 6
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 6
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- -1 egg white ion Chemical class 0.000 description 5
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- YIKKMWSQVKJCOP-ABXCMAEBSA-N 7-ketocholesterol Chemical compound C1C[C@H](O)CC2=CC(=O)[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]3[C@]21C YIKKMWSQVKJCOP-ABXCMAEBSA-N 0.000 description 4
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 4
- WDNOQSUMHJTAOV-RAUWIWGKSA-N PC(20:5(5Z,8Z,11Z,14Z,17Z)/P-18:1(11Z)) Chemical compound CCCCCC\C=C/CCCCCCCC\C=C/OC(COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC WDNOQSUMHJTAOV-RAUWIWGKSA-N 0.000 description 4
- CWRILEGKIAOYKP-SSDOTTSWSA-M [(2r)-3-acetyloxy-2-hydroxypropyl] 2-aminoethyl phosphate Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCCN CWRILEGKIAOYKP-SSDOTTSWSA-M 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 241000894007 species Species 0.000 description 4
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 235000020776 essential amino acid Nutrition 0.000 description 3
- 239000003797 essential amino acid Substances 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 239000011669 selenium Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 229930003571 Vitamin B5 Natural products 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 2
- 229960002079 calcium pantothenate Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 2
- 235000009492 vitamin B5 Nutrition 0.000 description 2
- 239000011675 vitamin B5 Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- YYSFWGQAKJTHRE-MEOKJUQFSA-N 1-(11Z)-icosenoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCC\C=C/CCCCCCCCCC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C YYSFWGQAKJTHRE-MEOKJUQFSA-N 0.000 description 1
- NMJCSTNQFYPVOR-VHONOUADSA-N 1-oleoyl-2-stearoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCC\C=C/CCCCCCCC NMJCSTNQFYPVOR-VHONOUADSA-N 0.000 description 1
- PYVRVRFVLRNJLY-MZMPXXGTSA-N 1-oleoyl-sn-glycero-3-phosphoethanolamine zwitterion Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)COP(O)(=O)OCCN PYVRVRFVLRNJLY-MZMPXXGTSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- CFWRDBDJAOHXSH-SECBINFHSA-N 2-azaniumylethyl [(2r)-2,3-diacetyloxypropyl] phosphate Chemical compound CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OCCN CFWRDBDJAOHXSH-SECBINFHSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 241000208686 Eucommiaceae Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000207836 Olea <angiosperm> Species 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 235000002725 Olea europaea Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000001948 isotopic labelling Methods 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 238000001946 ultra-performance liquid chromatography-mass spectrometry Methods 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/02—Breeding vertebrates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/12—Animal feeding-stuffs obtained by microbiological or biochemical processes by fermentation of natural products, e.g. of vegetable material, animal waste material or biomass
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Birds (AREA)
- Environmental Sciences (AREA)
- Mycology (AREA)
- Botany (AREA)
- Animal Behavior & Ethology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Sustainable Development (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses an eucommia ulmoides egg and a production method thereof. The production method of the eucommia ulmoides egg provided by the invention comprises the following steps: feeding laying hens to 70-75 days old by adopting a laying hen daily ration, and then feeding by adopting a laying hen feed to obtain eucommia ulmoides eggs; the layer feed comprises layer daily ration and additives, the additives are eucommia ulmoides leaf powder, fermented eucommia ulmoides leaf powder and/or eucommia ulmoides leaf extract, and the dosage of the additives is as follows: the amount of the eucommia ulmoides leaf powder is 1 to 3.5 percent of the daily ration of the laying hens; the amount of the fermented eucommia leaf powder is 2-5 per mill of the daily ration of the laying hen; the amount of the eucommia ulmoides leaf extract is 1-2 per mill of the daily ration of the laying hens. Compared with the common eggs, the eucommia ulmoides eggs produced by the laying hens fed by the eucommia ulmoides feed have the advantages that the content of DHA and EPA glycerophospholipids is increased, the B vitamins are obviously increased, and the content of histidine is obviously increased. The eucommia ulmoides egg is rich in nutrition, safe, high-quality, suitable for being eaten by many people such as hyperlipidemia and the like, and particularly suitable for being eaten by children.
Description
Technical Field
The invention relates to an eucommia ulmoides egg and a production method thereof, and belongs to the technical field of eucommia ulmoides egg production.
Background
Eucommia ulmoides (Eucommia ulmoides Oliv.) is a plant of genus Eucommiaceae (Eucomiaceae) Eucommia, is a residual wiggery plant in the geological history of China and is a secondary protective wild plant in China. Eucommia bark is listed as the top grade as early as Shen nong Ben Cao Jing. The record of the pharmacopoeia of the people's republic of China: cortex Eucommiae has effects of regulating blood pressure, nourishing liver and kidney, strengthening tendons and bones, and preventing miscarriage, and can be used for treating liver and kidney deficiency, soreness of waist and knees, weakness of bones and muscles, dizziness, pregnant hemorrhage, and threatened abortion. Eucommia bark is 'treasure' in the whole body, is not only an important national strategic resource in China, but also a unique and rare medicinal material in China, and has an important position in the industries of ecological protection, medical care, green cultivation and the like.
Eucommia bark is traditionally used as the drug. Recent studies have demonstrated that: the chemical components of eucommia ulmoides leaves are similar to those of bark, and the eucommia ulmoides leaves have similar pharmacological action with the bark, namely the leaves and the bark have the same effect. At present, eucommia ulmoides leaves are already recorded in pharmacopoeia of the people's republic of China and feed raw material catalogues, and are newly published substances which are used as medicines and food. The eucommia ulmoides leaves contain various nutrient substances such as crude protein, crude fat, vitamins, amino acid and the like, can be used for feeding chickens, cattle, sheep, pigs and the like, can meet most of nutritional requirements required by the growth and development of animals, improve the immunity of livestock and poultry, reduce the occurrence of diseases and the use of antibiotics, and can greatly improve the quality of meat and eggs of the livestock and poultry, and is safe and high-quality. The application of the eucommia ulmoides leaves as the laying hen feed additive is necessary to be researched.
Disclosure of Invention
The eucommia ulmoides egg provided by the invention is rich in nutrition, safe and high-quality, is suitable for being eaten by many people such as hyperlipidemia and the like, and is particularly suitable for being eaten by children.
The invention firstly provides a preparation method of fermented eucommia leaf powder, which comprises the following steps:
s1, crushing the eucommia leaves to obtain eucommia leaf powder, and then steaming;
s2, adding Aspergillus niger into the eucommia ulmoides leaf powder obtained in the step S1, and uniformly mixing; then adding the aqueous solution of bacillus subtilis and aspergillus oryzae to obtain a mixed material; carrying out aerobic fermentation on the mixed material;
s3, inoculating enterococcus faecalis into the aerobically fermented material, continuing to ferment, and drying the fermented material to obtain the enterococcus faecalis.
In the above preparation method, in step S1, the folium cortex eucommiae powder is sieved by a 40-mesh sieve;
the steaming conditions are as follows: the temperature is 60-80 ℃, and the time is 20-30 min;
in step S2, the inoculation amount of Aspergillus niger is 3% -8%;
the inoculation amount of the bacillus subtilis is 0.1-0.5%, preferably 0.3%, and the inoculation amount of the aspergillus oryzae is 0.1-0.5%, preferably 0.3%;
the addition amount of water is 40-50% of the dry weight of the eucommia ulmoides leaf powder.
In the above preparation method, in step S2, the aerobic fermentation conditions are as follows:
turning the pile once every day at the temperature of 25-30 ℃, controlling the relative humidity of the fermentation chamber to be 70-80%, and fermenting for 5-7 d;
in the step S3, the inoculation amount of the enterococcus faecalis is 1-5%, preferably 1%;
the fermentation conditions are as follows: the temperature is 25-30 ℃, and the time is 24-36 h;
the drying conditions are as follows: drying at 40-45 ℃ until the water content of the material reaches 5% -10%.
The fermented eucommia leaf powder prepared by the method also belongs to the protection scope of the invention.
The application of the eucommia ulmoides leaf powder, the fermented eucommia ulmoides leaf powder and the eucommia ulmoides leaf extract in serving as an additive of the laying hen feed also belongs to the protection range of the invention;
the eucommia ulmoides leaf extract is prepared by the following method: soaking folium Eucommiae in water, reflux extracting, concentrating the obtained extractive solution, and drying;
soaking the raw materials in water at 70-80 ℃, repeatedly performing reflux extraction for many times, and then combining the extracting solutions;
the eucommia ulmoides leaf powder is sieved by a 40-mesh sieve.
The additive amount of the laying hen feed is as follows:
the amount of the eucommia leaf powder is 1 to 3.5 percent of the daily ration of the laying hen;
the amount of the fermented eucommia ulmoides leaf powder is 2-5 per mill of the daily ration of the laying hens;
the amount of the eucommia ulmoides leaf extract is 1-2 per mill of the daily ration of the laying hens.
The invention further provides a layer feed additive which is eucommia ulmoides leaf powder, the fermented eucommia ulmoides leaf powder and/or an eucommia ulmoides leaf extract; the mass ratio of the eucommia ulmoides leaf powder to the fermented eucommia ulmoides leaf powder to the eucommia ulmoides leaf extract is 10-35: 2-5: 1, preferably 10: 2: 1.
the invention further provides a layer feed, which comprises layer daily ration and an additive, wherein the additive is eucommia ulmoides leaf powder, fermented eucommia ulmoides leaf powder and/or eucommia ulmoides leaf extract;
the amounts of the additives were as follows:
the amount of the eucommia ulmoides leaf powder is 1 to 3.5 percent of the daily ration of the laying hen;
the amount of the fermented eucommia ulmoides leaf powder is 2-5 per mill of the daily ration of the laying hens;
the amount of the eucommia ulmoides leaf extract is 1-2 per mill of the daily ration of the laying hens.
On the basis of the laying hen feed, the invention also provides a production method of eucommia ulmoides eggs, which comprises the following steps:
the eucommia ulmoides eggs can be obtained by feeding laying hens to 70-75 days old by adopting a laying hen daily ration and then feeding the laying hens by adopting the laying hen feed.
The additive provided by the invention has obvious influence on the endogenous metabolites of the eggs. Compared with common eggs, the eucommia ulmoides eggs produced by laying hens fed with the eucommia ulmoides feed have the advantages that B vitamins are obviously increased, and glycerophospholipids containing DHA and EPA are increased, particularly PC (22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z)), LysoPC (22:6(4Z,7Z,10Z,13Z,16Z,19Z)) in egg white and PC (22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z)) in egg yolk are increased remarkably, and PC (20:5(5Z,8Z,11Z,14Z,17Z)/P-18:1(11Z)) in egg yolk are reduced. The total amount of protein and amino acid, vitamin A, selenium, calcium, zinc and iron in the eucommia ulmoides eggs are all obviously increased, the content of 7 essential amino acids is all increased, and the content of histidine is obviously increased. Therefore, the eucommia ulmoides eggs are rich in nutrition, safe and high in quality, are suitable for being eaten by multiple people such as hyperlipidemia and are particularly suitable for being eaten by children.
Drawings
FIG. 1 is a total ion flow diagram of eucommia ulmoides egg white.
Fig. 2 is a general egg white ion flow diagram.
Fig. 3 is a total ion flow diagram of eucommia ulmoides yolk.
Fig. 4 is a general yolk total ion flow diagram.
FIG. 5 shows PCA of egg white, wherein A represents eucommia ulmoides egg white and B represents normal egg white.
FIG. 6 shows PCA of egg yolk, wherein A represents eucommia ulmoides egg yolk and B represents normal egg yolk.
FIG. 7 shows OPLS-DA of egg white, wherein A represents eucommia ulmoides egg white and B represents normal egg white.
FIG. 8 shows OPLS-DA of egg yolk, wherein A represents eucommia ulmoides egg yolk and B represents normal egg yolk.
FIG. 9 shows the color comparison of eucommia ulmoides oliv and common olives.
Detailed Description
The experimental procedures used in the following examples are all conventional procedures unless otherwise specified.
Materials, reagents and the like used in the following examples are commercially available unless otherwise specified.
Example 1 preparation of folium Eucommiae feed
1. Preparation of folium Eucommiae powder
Drying the eucommia leaves: picking fresh folium Eucommiae, removing impurities, and air drying in sunlight greenhouse.
Crushing: pulverizing folium Eucommiae into 40 mesh fine powder with a pulverizer.
2. Preparation method of fermented folium Eucommiae powder
Preparing raw materials: selecting the crushed eucommia leaf powder for later use.
Steaming: steaming folium Eucommiae powder by steam method. The steam temperature is about 60 deg.C, and the steaming time is 25 min.
Inoculation: and (4) inoculating when the eucommia ulmoides leaf powder is cooled to 38-40 ℃. Aspergillus niger (the inoculum size is 5 percent and purchased from China Industrial microorganism culture preservation management center) is added into eucommia leaf powder and uniformly mixed, then Bacillus subtilis (0.3 percent and purchased from China Industrial microorganism culture preservation management center) and Aspergillus oryzae (0.3 percent and purchased from China Industrial microorganism culture preservation management center) are added into pure water and uniformly mixed, and then the mixture is uniformly mixed with the materials, the addition amount of the pure water is 40 percent of the dry weight of the materials, and finally the mixture is sent into a fermentation chamber.
Aerobic fermentation: and transferring the mixed materials to a fermentation chamber, controlling the temperature of the fermentation chamber at 25-30 ℃, turning the piles once every day, controlling the relative humidity of the fermentation chamber at 70-80%, and fermenting for 6 d.
After the aerobic fermentation is finished, the fermented feed is scattered, enterococcus faecalis (1 percent, purchased from China Industrial microbial strain preservation management center) is inoculated into the material, and then the material is filled into a one-way valve fermentation bag for fermentation. The temperature of the fermentation chamber is controlled to be 25-30 ℃, and the fermentation time is 32 hours.
And (3) drying: transferring the fermented material to a drying workshop, controlling the drying temperature to be 40-45 ℃, and waiting until the moisture of the material reaches 8%.
3. Preparation method of folium Eucommiae extract
Soaking folium Eucommiae in 70 deg.C water, reflux extracting, repeating for 3 times, mixing extractive solutions, concentrating under reduced pressure, and spray drying the concentrated solution with spray tower to obtain folium Eucommiae extract.
Example 2 feeding of laying hens with folium Eucommiae feed as additive
1) Mixing folium Eucommiae powder, fermented folium Eucommiae powder and folium Eucommiae extract with daily ration (laying hen compound feed 106A), and feeding with constant feeding management system.
2) Selecting high-quality layer chicken variety (Nongda seventh), feeding the layer chicken in the age of 70 days until the layer chicken is rejected.
Wherein the mixing ratio of folium Eucommiae powder, fermented folium Eucommiae powder and folium Eucommiae extract to daily ration is 2%, 4 ‰ and 2 ‰, respectively.
Example 3 feed Effect of eucommia ulmoides
First, analysis method
1. Metabolome analysis
1) Sample preparation
After the egg white and the egg yolk are respectively freeze-dried, 20mg of sample is weighed, and 1000 mul of extracting solution (methanol: acetonitrile: water: 2: 1(V/V), isotope labeling internal standard mixture is added); ultrasonic extraction, centrifuging, taking the supernatant, and detecting in a sample bottle.
2) UPLC-MS analysis method
The target compound was chromatographed on a Waters ACQUITY UPLC BEH Amide (2.1 mm. times.100 mm,1.7 μm) liquid chromatography column using Vanqish (thermo Fisher scientific) ultra performance liquid chromatography. The liquid chromatogram is characterized in that the phase A is a water phase containing 25mmol/L ammonium acetate and 25mmol/L ammonia water, and the phase B is acetonitrile. Temperature of the sample pan: 4 ℃, injection volume: 3 μ L.
Thermo Q active HFX mass spectrometer. The detailed parameters are as follows: 30Arb for shear gas flow rate, 25Arb for Aux gas flow rate, 350 ℃ for Capillary temperature, 60000 for Full MS resolution, 7500 for MS/MS resolution, 10/30/60 for fusion energy, NCE mode, 3.6kV (positive).
2. Quantitative analysis of protein, amino acid, vitamin A and elements
The protein is analyzed by a GB5009.5-2010 method, the amino acid content is analyzed by an amino acid analyzer according to a GB/T5009.124-2003 method, the vitamin A is analyzed by a GB/T5009.82-2003 method, and a plurality of elements are quantitatively analyzed by an atomic absorption spectrophotometer.
Second, analysis results
The total ion flow graph of egg white and egg yolk is shown in figures 1-4.
After the eucommia ulmoides is added into the feed, the endogenous metabolites of the eggs are obviously changed. The egg white and yolk of eucommia ulmoides egg have great difference with the metabolites in the egg white and yolk of common egg, as shown in fig. 5-8.
1. Comparison of eucommia ulmoides egg white with common egg white endogenous metabolites
Upon analysis, a total of 317 metabolites were detected from egg white as shown in table 1.
TABLE 1 comparison of metabolites in eucommia ulmoides eggs and common egg white
(1) The phospholipid content is obviously changed
As can be seen from table 1, the total of 29 phospholipids increased in the eucommia ulmoides egg white compared to the normal egg white, including PC (15 species), PE (2 species) LysoPC (10 species), LysoPE (2 species). Among them, the difference multiples of more than 2 are mainly PC (18:2(9Z,12Z)/15:0), PC (20:4(8Z,11Z,14Z,17Z)/15:0), LysoPC (16:1(9Z)), LysoPC (18:3(6Z,9Z,12Z)), LysoPC (20:1(11Z)), LysoPC (22:6(4Z,7Z,10Z,13Z,16Z,19Z)), LysoPE (18:1(9Z)/0:0), and the like.
PC: phosphatidylcholine (phosphatidylcholine), also known as lecithin; PE: phosphatidylethanolamine (also known as cephalin); LysoPC: a lysophospholipid; LysoPE: lysophosphatidylethanolamine.
Phospholipids are lipid compounds containing phospholipid root, and play important roles in activating cells, balancing secretion of hormones, enhancing immunity and regenerative power of human bodies, and the like. In addition, phospholipid also has effects of promoting fat metabolism, preventing fatty liver, reducing serum cholesterol, improving blood circulation, and preventing cardiovascular diseases.
(2) Changes in vitamin content
As can be seen from table 1, nicotinamide (vitamin B3), riboflavin (vitamin B2), pantothenic acid (vitamin B5), and panthenol (provitamin B5) were significantly increased in the eucommia ulmoides oliver than in the common egg white.
2. Comparison of endogenous metabolites in eucommia ulmoides yolk with those in common yolk
334 metabolites were detected from egg yolk by analysis, as shown in Table 2.
TABLE 2 comparison of metabolites in the yolk of eucommia ulmoides and common eggs
(1) Significant change of phospholipid
As seen from Table 2, the content of 59 kinds of phospholipids, including PC (38 kinds), PE (7 kinds), LysoPC (7 kinds) and LysoPE (7 kinds), was increased in the eucommia ulmoides yolk compared to the common yolk. Among them, the difference multiples of more than 2 are mainly PC (18:1(9Z)/18:0), PC (20:4(8Z,11Z,14Z,17Z)/20:3(8Z,11Z,14Z)), PC (20:5(5Z,8Z,11Z,14Z,17Z)/P-18:1(11Z)), PC (24:1(15Z)/14:1(9Z)), and the like.
(2) The vitamin content is obviously increased
As can be seen from table 2, thiamine (vitamin B1), riboflavin (vitamin B2), niacinamide (vitamin B3), pantothenic acid (vitamin B5), biotin, and vitamin B7 were significantly increased in the yolk of eucommia ulmoides oliv as compared to the common yolk.
3. Comparison of relative contents of several important components in eucommia ulmoides egg and common egg
The comparison results of several important ingredients in the egg white and egg yolk of eucommia ulmoides egg with the common egg are shown in tables 3 and 4. The research result shows that compared with the common egg, the vitamin B complex of the eucommia ulmoides egg is obviously increased.
DHA (docosahexaenoic acid) is docosahexaenoic acid, commonly known as brain gold, is an unsaturated fatty acid which is very important to human body, is a main component for growth and maintenance of nervous system cells, and is an important constituent of brain and retina. EPA (eicosapentaenoic acid) is eicosapentaenoic acid, helps growth and development, reduces cholesterol and triglyceride, and promotes metabolism of saturated fatty acid in vivo.
As can be seen from tables 3 and 4, both DHA and EPA containing glycerophospholipids were increased, and in particular, PC (22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z)), LysoPC (22:6(4Z,7Z,10Z,13Z,16Z,19Z)) in egg white and PC (22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z)) in egg yolk and PC (20:5(5Z,8Z,11Z,14Z,17Z)/P-18:1(11Z)) were significantly increased.
TABLE 3 comparison of the content of several important components in the eggs from eucommia ulmoides and common eggs
TABLE 4 comparison of the content of several important components in the yolk of eucommia ulmoides oliv and common egg
As can be seen from Table 5, the 7-ketocholesterol in the egg yolk of eucommia ulmoides oliv was reduced by 9.09% (7-ketocholesterol is the most common product of the reaction between cholesterol and oxygen radicals, and is the highest concentration of oxysterol in blood and arterial plaque and various other diseased tissues and cells of patients with coronary artery disease. unlike cholesterol, 7-ketocholesterol has sustained toxicity to cells and its physiological function in humans or other complex organisms is unknown).
4. Comparison of protein, amino acid, vitamin A and element contents of eucommia ulmoides egg and common egg
The contents of proteins, amino acids, vitamin a and elements in the eucommia ulmoides chicken eggs and the common chicken eggs are shown in table 5.
TABLE 5 comparison of the protein, amino acid and vitamin A and element content of eucommia ulmoides oliv and common egg
As can be seen from Table 5, compared with the common eggs, the eucommia ulmoides eggs have the advantages that the protein is increased by 13.47%, the amino acid is increased by 36.4%, the vitamin A is increased by 12.15%, the selenium is increased by 58.47%, the calcium is increased by 62.92%, the zinc is increased by 7.14%, and the iron is increased by 10.80%. Among the detected amino acids, the content of 7 essential amino acids in the eucommia ulmoides egg is increased. In addition, the histidine content in the eucommia ulmoides eggs is increased by 61.11 percent compared with the common eggs. Because children cannot synthesize histidine and need to take the histidine from food, the eucommia ulmoides olives are particularly suitable for children to eat.
Lead, mercury and cadmium are not detected in the eucommia ulmoides eggs and the common eggs, and the product is safe and reliable.
5. Comparison of color and taste of eucommia ulmoides egg and common egg
Compared with the common eggs, the eucommia ulmoides egg is clear and transparent in egg white and fresh and yellow in yolk, as shown in fig. 9.
After 20 people eat the eggs, the eucommia ulmoides oliv eggs are considered to have more delicate and smooth mouthfeel than the common eggs.
As can be seen from the above experimental results, the leaves of eucommia ulmoides have a significant effect on the endogenous metabolites of eggs. Compared with common eggs, the vitamin B group of the eucommia ulmoides eggs is obviously increased, the glycerophospholipids containing DHA and EPA are all increased, and particularly, the increase of PC (22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z)), LysoPC (22:6(4Z,7Z,10Z,13Z,16Z,19Z)) in egg white and PC (22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(11Z)) in egg yolk and PC (20:5(5Z,8Z,11Z,14Z,17Z)/P-18:1(11Z)) in egg yolk is very obvious, and the 7-ketocholesterol in the eucommia ulmoides eggs is reduced. The total amount of protein and amino acid, vitamin A, selenium, calcium, zinc and iron in the eucommia ulmoides eggs are all obviously increased, the content of 7 essential amino acids is all increased, and the content of histidine is obviously increased. Therefore, the eucommia ulmoides eggs are rich in nutrition, safe and high in quality, are suitable for being eaten by multiple people such as hyperlipidemia and are particularly suitable for being eaten by children.
Claims (10)
1. A preparation method of fermented eucommia ulmoides leaf powder comprises the following steps:
s1, crushing the eucommia leaves to obtain eucommia leaf powder, and then steaming;
s2, adding Aspergillus niger into the eucommia ulmoides leaf powder obtained in the step S1, and uniformly mixing; then adding the aqueous solution of bacillus subtilis and aspergillus oryzae to obtain a mixed material; carrying out aerobic fermentation on the mixed material;
s3, inoculating enterococcus faecalis into the aerobically fermented material, continuing to ferment, and drying the fermented material to obtain the enterococcus faecalis.
2. The method of claim 1, wherein: in step S1, the folium cortex eucommiae powder is sieved by a 40-mesh sieve;
the steaming conditions are as follows: the temperature is 60-80 ℃, and the time is 20-30 min;
in step S2, the inoculation amount of Aspergillus niger is 3% -8%;
the inoculation amount of the bacillus subtilis is 0.1-0.5%, and the inoculation amount of the aspergillus oryzae is 0.1-0.5%;
the addition amount of water is 40-50% of the dry weight of the eucommia ulmoides leaf powder.
3. The method of manufacturing according to claim 1 or, characterized in that: in step S2, the aerobic fermentation conditions are:
turning the pile once every day at the temperature of 25-30 ℃, controlling the relative humidity of the fermentation chamber to be 70-80%, and fermenting for 5-7 d;
in the step S3, the inoculation amount of the enterococcus faecalis is 1-5%;
the fermentation conditions are as follows: the temperature is 25-30 ℃, and the time is 24-36 h;
the drying conditions are as follows: drying at 40-45 ℃ until the water content of the material reaches 5% -10%.
4. Fermented eucommia ulmoides leaf powder prepared by the method of any one of claims 1 to 3.
5. Use of folium Eucommiae powder, the fermented folium Eucommiae powder and/or folium Eucommiae extract of claim 4 as additive for layer chicken feed;
the eucommia ulmoides leaf extract is prepared by the following method: soaking folium Eucommiae in water, reflux extracting, concentrating the obtained extractive solution, and drying;
the eucommia ulmoides leaf powder is sieved by a 40-mesh sieve.
6. Use according to claim 5, characterized in that: the additive amount of the laying hen feed is as follows:
the amount of the eucommia leaf powder is 1 to 3.5 percent of the daily ration of the laying hen;
the amount of the fermented eucommia ulmoides leaf powder is 2-5 per mill of the daily ration of the laying hens;
the amount of the eucommia ulmoides leaf extract is 1-2 per mill of the daily ration of the laying hens.
7. A layer feed additive, which is eucommia ulmoides leaf powder, the fermented eucommia ulmoides leaf powder and/or the eucommia ulmoides leaf extract of claim 4;
the mass ratio of the eucommia ulmoides leaf powder to the fermented eucommia ulmoides leaf powder to the eucommia ulmoides leaf extract is 10-35: 2-5: 1.
8. a layer feed, comprising layer ration and an additive, wherein the additive is eucommia ulmoides leaf powder, the fermented eucommia ulmoides leaf powder and/or the eucommia ulmoides leaf extract according to claim 4.
9. The laying hen feed of claim 8, wherein: the amounts of the additives were as follows:
the amount of the eucommia ulmoides leaf powder is 1 to 3.5 percent of the daily ration of the laying hen;
the amount of the fermented eucommia ulmoides leaf powder is 2-5 per mill of the daily ration of the laying hens;
the amount of the eucommia ulmoides leaf extract is 1-2 per mill of the daily ration of the laying hens.
10. A production method of eucommia ulmoides egg comprises the following steps:
feeding laying hens by using a laying hen daily ration until the laying hens are 70-75 days old, and then feeding the laying hens by using the laying hen feed according to claim 8 or 9 to obtain the eucommia ulmoides eggs.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210094685.5A CN114451487A (en) | 2022-01-26 | 2022-01-26 | Eucommia ulmoides egg and production method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210094685.5A CN114451487A (en) | 2022-01-26 | 2022-01-26 | Eucommia ulmoides egg and production method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114451487A true CN114451487A (en) | 2022-05-10 |
Family
ID=81412509
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210094685.5A Pending CN114451487A (en) | 2022-01-26 | 2022-01-26 | Eucommia ulmoides egg and production method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114451487A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115399410A (en) * | 2022-09-15 | 2022-11-29 | 广东仲康源生物科技有限公司 | Compound feed additive for improving egg quality and serial preparation method and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106509339A (en) * | 2016-11-16 | 2017-03-22 | 山西大禹生物工程股份有限公司 | Method for producing eucommia ulmoides leaf biological feed additive from multiple strains through solid-state fermentation |
-
2022
- 2022-01-26 CN CN202210094685.5A patent/CN114451487A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106509339A (en) * | 2016-11-16 | 2017-03-22 | 山西大禹生物工程股份有限公司 | Method for producing eucommia ulmoides leaf biological feed additive from multiple strains through solid-state fermentation |
Non-Patent Citations (2)
Title |
---|
张琳杰;彭胜;张昌伟;王志宏;周云雷;彭密军;张水寒;: "日粮中添加杜仲素对鸡蛋品质的影响", 广东农业科学, no. 17, pages 113 * |
段明房;胡红伟;闫凌鹏;麻啸涛;邢俊德;杨京娥;党亚朋;庄自佳;: "发酵杜仲叶粉对蛋鸡蛋、肉品质和风味及盲肠微生物的影响", 中国饲料, no. 06, pages 20 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115399410A (en) * | 2022-09-15 | 2022-11-29 | 广东仲康源生物科技有限公司 | Compound feed additive for improving egg quality and serial preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100362091C (en) | A selenium yeast product, a method of preparing a selenium yeast product and the use of the product for preparing food, a dietary supplement or a drug | |
CN108771242A (en) | A kind of coronoid process dissipate capsule bacterium Fermentation Function compound and its preparation method and application | |
KR20110055697A (en) | Photosynthetic microorganisms enriched in selenium using selenohydroxy acid compounds, uses thereof in nutrition, cosmetics and pharmacy | |
KR101873514B1 (en) | Method for producing l-carnitine rich fermentation products and the fermentation products produced by the same | |
CN108260731A (en) | A kind of nutritive cream for controlling pet dog cat weight | |
KR101836918B1 (en) | Feed Composition for Mealworm, Breeding Method for Mealworm Using the Same, And Food Composition Obtained Therefrom | |
CN103299824B (en) | Method for preparing phellinus igniarius sclertium from fresh, tender and sweet corn | |
CN109007295A (en) | A kind of Moringa feed addictive, preparation method and purposes | |
CN114451487A (en) | Eucommia ulmoides egg and production method thereof | |
RU2366271C1 (en) | Forage additive as preventive and treatment medium for domestic and farm animals | |
CN111903840A (en) | Compound ginkgo leaf feed additive rich in probiotics | |
KR100557467B1 (en) | Process for feeding fish and livestock a liquid extract of mushroom mycelial culture and product thereof | |
RU2473679C2 (en) | METHOD OF PRODUCING SELENIUM-CONTAINING BIOMASS PREPARATION OF Laetiporus sulphureus MZ-22 | |
KR102266858B1 (en) | Manufacturing method of feed for layer chicken | |
CA2020633C (en) | Mutant of pseudomonas, a strain yzh, and a process for producing 851 yzh nutrient solution by application of the strain | |
Šelepcová et al. | Influence of Rhaponticum carthamoides Wild on the growth of ruminal bacteria in vitro and on fermentation in an artificial rumen (Rusitec) | |
CN108094726A (en) | A kind of creep feed for enhancing pigling immunity and preparation method and application | |
RU2787730C1 (en) | Method for increasing the productivity and nonspecific resistance of the body of newborn calves | |
CN109497296A (en) | A kind of selenium-rich milk and production method based on fermentation process bioconversion selenium | |
Rutkowski et al. | Rapeseed meal XX. Influence of toxic compounds of rapeseed meal on the technological properties of propionic acid bacteria | |
RU2749830C1 (en) | Method for adapting highly productive cows to the conditions of an industrial complex in the winter stall period | |
CN114711193B (en) | Method for breeding Taihe black-bone chickens rich in brain gold | |
KR100829543B1 (en) | A crude drug composition for promoting memory which contains lactic acid bacteria fermentation product with an enhanced level of gamma-aminobutyric acid | |
KR100903562B1 (en) | Functional chungkookjang containing herb using bacillus subtilis cho47 | |
CN106520873A (en) | Preparation method for peptide chelated calcium of clanis bilineata tsingtauica larva |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |